Seer, Inc. (NASDAQ:SEER) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Seer, Inc. Third Quarter 2024 Earnings Conference Call [Operator Instructions].
Seer Inc. (SEER)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 2,300,000 | $4,531,000 | 0.32% | |
| 2. | Renaissance Technologies Jim Simons | 664,132 | $1,308,340 | +33% | 0% |
| 3. | D E Shaw D. E. Shaw | 616,271 | $1,214,054 | +39% | 0% |
| 4. | Millennium Management Israel Englander | 564,662 | $1,112,384 | -38% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 549,100 | $1,081,727 | +28% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.45 | 40,000 | Officer, Director | 807,744 | 2023-08-23 | Filing | |
| $19.00 | 22,620 | Large Shareholder | 22,620 | 2020-12-08 | Filing | |
| $19.00 | 21,310 | Large Shareholder | 21,310 | 2020-12-08 | Filing | |
| $19.00 | 12,190 | Large Shareholder | 12,190 | 2020-12-08 | Filing | |
| $19.00 | 19,230 | Large Shareholder | 19,230 | 2020-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.78 | 12,109 | 79,457 | 2024-06-14 | Filing | ||
| $2.03 | 52,857 | 1,436,285 | 2024-03-07 | Filing | ||
| $1.58 | 12,684 | 273,142 | 2024-02-22 | Filing | ||
| $1.58 | 12,684 | 480,511 | 2024-02-22 | Filing | ||
| $1.67 | 3,608 | Officer | 328,157 | 2024-02-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,791,042 | $11,234,623 | 0% | |
| 2. | 5,135,383 | $9,962,643 | 0.05% | |
| 3. | 4,307,203 | $8,355,973 | 0% | |
| 4. | 2,610,633 | $5,064,628 | 0% | |
| 5. | 2,056,000 | $3,988,640 | 0% |
News See All
Seer, Inc. (NASDAQ:SEER) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kathleen and I will be your conference operator today.
Seer, Inc. (NASDAQ:SEER) Q1 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Seer, Inc. First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Seer, Inc. (NASDAQ:SEER) Q4 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Seer Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Seer, Inc. (NASDAQ:SEER) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Seer Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Seer, Inc. (NASDAQ:SEER) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Seer, Inc. Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Seer, Inc. (NASDAQ:SEER) Q1 2023 Earnings Call Transcript
Operator: Good day. And thank you for standing by. Welcome to the Seer First Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised today's conference is being recorded.
Seer, Inc. (NASDAQ:SEER) Q4 2022 Earnings Call Transcript
Operator: Thank you for standing by and welcome to the Seer Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Seer, Inc. (NASDAQ:SEER) Q3 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Seer Inc. Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
5 Healthcare Stocks to Buy According to Lee Ainslie's Maverick Capital
In this piece, we will take a look at the 5 healthcare stocks to buy according to Lee Ainslie's Maverick Capital. If you want to learn more about Mr.